Price Alert

Phibro Animal Health Corp... (PAHC)

NASDAQ: PAHC · Real-Time Price · USD

30.43

-0.14 (-0.46%)

At close: Aug 15, 2025, 9:55 AM

Phibro Animal Health Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Revenue	1.19B	1.11B	1.05B	1.02B	999.51M	981.97M	976.67M	977.89M	978.14M	972.09M	960.15M	942.3M	907.3M	879.41M	852.84M	833.37M	798.97M	797.98M	805.85M
Cost of Revenue	813.97M	755.07M	719M	705.66M	697.66M	683.44M	679.38M	679.65M	678.07M	675.93M	670.71M	656.82M	630.52M	605.09M	580.93M	562.02M	536.82M	535.45M	542.47M
Gross Profit	376.71M	351.01M	327.76M	311.97M	301.85M	298.52M	297.29M	298.24M	300.07M	296.16M	289.44M	285.48M	276.78M	274.31M	271.91M	271.35M	262.15M	262.54M	263.37M
Operating Income	89.39M	76.06M	66.23M	47.83M	58.96M	57.32M	57.46M	71.85M	62.58M	63.22M	69.67M	70.59M	75.3M	76.24M	73.83M	74.91M	73.81M	75M	74.72M
Interest Income	2.26M	3.03M	3.92M	4.47M	4.16M	4.13M	3.81M	3.35M	2.71M	1.86M	1.27M	816K	641K	602K	715K	838K	1.08M	1.33M	1.58M
Pretax Income	50.55M	33.79M	32.52M	10.89M	25.93M	28.11M	36.65M	54.07M	45.03M	56.76M	68.18M	72.36M	76.06M	67.01M	59.53M	66.44M	66.74M	67.63M	68.47M
Net Income	31.79M	19.32M	17.41M	2.43M	13.18M	14.81M	20.75M	32.61M	28.61M	36.26M	46.51M	49.19M	58.79M	53.26M	48.6M	54.36M	42.86M	44.2M	43.3M
Selling & General & Admin	287.33M	274.95M	261.53M	264.24M	243M	241.3M	239.93M	226.39M	228.99M	224.44M	211.27M	206.38M	201.58M	198.18M	198.17M	196.54M	188.24M	187.44M	188.56M
Research & Development	29.19M	29.19M	29.19M	29.19M	24.39M	24.39M	24.39M	24.39M	20.83M	20.83M	20.83M	20.83M	17.76M	17.76M	17.76M	17.76M	13.74M	13.74M	13.74M
Other Expenses	12.18M	12.18M	12.18M	12.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	287.33M	274.95M	261.53M	264.24M	243M	241.3M	239.93M	226.39M	228.99M	224.44M	211.27M	206.38M	201.58M	198.18M	198.17M	196.54M	188.24M	187.44M	188.56M
Interest Expense	40.07M	36.27M	36.47M	37.51M	36.69M	35.3M	32.86M	28.55M	22.8M	17.19M	14.24M	13.27M	13.41M	14.19M	12.86M	11.23M	10.67M	11.25M	12.54M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.1B	1.03B	980.53M	969.9M	940.66M	924.75M	919.3M	906.04M	907.06M	900.36M	881.98M	863.2M	832.1M	803.27M	779.11M	758.56M	725.06M	722.88M	731.03M
Income Tax Expense	18.76M	14.47M	15.11M	8.46M	12.75M	13.3M	15.9M	21.46M	16.42M	20.5M	21.67M	23.17M	17.27M	13.75M	10.93M	12.08M	23.78M	23.32M	25.07M
Shares Outstanding (Basic)	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.48M	40.45M	40.45M
Shares Outstanding (Diluted)	40.71M	40.72M	40.58M	40.6M	40.52M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M
EPS (Basic)	0.79	0.48	0.43	0.06	0.32	0.36	0.51	0.81	0.72	0.91	1.16	1.22	1.45	1.31	1.20	1.34	1.06	1.09	1.06
EPS (Diluted)	0.78	0.48	0.43	0.06	0.32	0.36	0.51	0.81	0.72	0.91	1.16	1.22	1.45	1.31	1.20	1.34	1.06	1.09	1.06
EBITDA	128.96M	107.42M	106.81M	79.29M	92.87M	91.34M	90.76M	113.62M	98.63M	98.31M	104.26M	104.6M	107.93M	107.98M	105.66M	106.92M	107.05M	108.57M	108.52M
EBIT	82.71M	62.25M	57.22M	32.77M	44.39M	45.9M	53.48M	69.1M	60.97M	70.94M	80.88M	84.43M	87.95M	78.8M	71.62M	78.5M	78.03M	79.71M	81.01M
Depreciation & Amortization	42.4M	38.98M	36.31M	36.18M	35.55M	34.84M	34.43M	34.01M	33.84M	33.8M	33.3M	32.7M	32.14M	31.62M	31.7M	31.89M	32.21M	32.54M	32.6M